Aadi Short Term Investments vs Capital Stock Analysis

AADI Stock

USD 1.84 0.02 1.10%

Aadi Bioscience financial indicator trend analysis is way more than just evaluating Aadi Bioscience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aadi Bioscience is a good investment. Please check the relationship between Aadi Bioscience Short Term Investments and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Short Term Investments vs Capital Stock

Short Term Investments vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aadi Bioscience Short Term Investments account and Capital Stock. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Aadi Bioscience's Short Term Investments and Capital Stock is -0.29. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Aadi Bioscience, assuming nothing else is changed. The correlation between historical values of Aadi Bioscience's Short Term Investments and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Aadi Bioscience are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Short Term Investments i.e., Aadi Bioscience's Short Term Investments and Capital Stock go up and down completely randomly.

Correlation Coefficient

-0.29

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Short Term Investments

Short Term Investments is an item under the current assets section of Aadi Bioscience balance sheet. It contains any investments Aadi Bioscience undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Aadi Bioscience can easily liquidate in the marketplace.

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Most indicators from Aadi Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Enterprise Value Multiple is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	105K	159K	171K	122.1K
Interest Income	13K	2.4M	6.5M	6.8M

Reconciled Depreciation Interest Income

Aadi Bioscience fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Short Long Term Debt Total	Total Current Liabilities	Other Assets	Non Current Liabilities Total	Total Liab	Short Term Debt	Common Stock	Other Current Liab	Accounts Payable	Other Current Assets	Non Current Assets Total	Non Currrent Assets Other	Property Plant And Equipment Net	Current Deferred Revenue	Short Term Investments	Common Stock Total Equity	Property Plant And Equipment Gross
Total Assets		0.99	-0.77	-0.85	0.8	1.0	0.84	0.95	1.0	0.13	0.65	0.93	0.81	0.73	0.06	0.45	0.94	0.88	0.92	0.88	0.96	0.67	0.74	0.73	-0.39	0.66
Total Stockholder Equity	0.99		-0.8	-0.83	0.81	1.0	0.8	0.94	0.99	0.0	0.53	0.9	0.8	0.63	-0.07	0.48	0.92	0.83	0.91	0.85	0.95	0.63	0.7	0.73	-0.44	0.62
Net Debt	-0.77	-0.8		0.61	-0.99	-0.79	-0.42	-0.72	-0.77	0.13	-0.33	-0.67	-0.63	-0.41	0.17	-0.56	-0.61	-0.75	-0.6	-0.7	-0.74	-0.34	-0.64	-0.18	0.25	-0.33
Retained Earnings	-0.85	-0.83	0.61		-0.66	-0.83	-0.85	-0.95	-0.85	-0.32	-0.68	-0.83	-0.44	-0.7	-0.27	-0.56	-0.93	-0.8	-0.92	-0.84	-0.79	-0.82	-0.8	-0.61	0.27	-0.81
Cash	0.8	0.81	-0.99	-0.66		0.81	0.48	0.75	0.8	-0.02	0.42	0.72	0.63	0.5	-0.06	0.54	0.65	0.8	0.64	0.75	0.77	0.4	0.68	0.2	-0.24	0.4
Cash And Short Term Investments	1.0	1.0	-0.79	-0.83	0.81		0.79	0.93	1.0	0.06	0.58	0.9	0.83	0.68	-0.01	0.47	0.92	0.84	0.9	0.84	0.95	0.61	0.72	0.73	-0.41	0.6
Common Stock Shares Outstanding	0.84	0.8	-0.42	-0.85	0.48	0.79		0.88	0.83	0.32	0.7	0.93	0.48	0.72	0.26	0.19	0.94	0.82	0.94	0.91	0.86	0.94	0.58	0.75	-0.46	0.94
Other Stockholder Equity	0.95	0.94	-0.72	-0.95	0.75	0.93	0.88		0.95	0.16	0.64	0.91	0.6	0.69	0.09	0.58	0.96	0.86	0.95	0.89	0.89	0.79	0.82	0.68	-0.31	0.79
Total Current Assets	1.0	0.99	-0.77	-0.85	0.8	1.0	0.83	0.95		0.12	0.64	0.93	0.81	0.73	0.05	0.46	0.94	0.87	0.92	0.87	0.95	0.66	0.74	0.74	-0.38	0.65
Short Long Term Debt Total	0.13	0.0	0.13	-0.32	-0.02	0.06	0.32	0.16	0.12		0.78	0.27	-0.02	0.7	1.0	-0.19	0.26	0.33	0.22	0.29	0.15	0.41	0.23	0.11	0.15	0.41
Total Current Liabilities	0.65	0.53	-0.33	-0.68	0.42	0.58	0.7	0.64	0.64	0.78		0.72	0.43	0.99	0.72	0.13	0.69	0.79	0.65	0.7	0.62	0.68	0.68	0.47	0.02	0.68
Other Assets	0.93	0.9	-0.67	-0.83	0.72	0.9	0.93	0.91	0.93	0.27	0.72		0.69	0.78	0.2	0.21	0.94	0.95	0.93	0.98	0.98	0.83	0.63	0.67	-0.51	0.83
Non Current Liabilities Total	0.81	0.8	-0.63	-0.44	0.63	0.83	0.48	0.6	0.81	-0.02	0.43	0.69		0.57	-0.09	0.16	0.62	0.63	0.58	0.56	0.79	0.19	0.44	0.68	-0.4	0.18
Total Liab	0.73	0.63	-0.41	-0.7	0.5	0.68	0.72	0.69	0.73	0.7	0.99	0.78	0.57		0.63	0.15	0.74	0.83	0.69	0.74	0.71	0.65	0.7	0.55	-0.05	0.65
Short Term Debt	0.06	-0.07	0.17	-0.27	-0.06	-0.01	0.26	0.09	0.05	1.0	0.72	0.2	-0.09	0.63		-0.22	0.2	0.26	0.15	0.23	0.08	0.36	0.17	0.04	0.16	0.36
Common Stock	0.45	0.48	-0.56	-0.56	0.54	0.47	0.19	0.58	0.46	-0.19	0.13	0.21	0.16	0.15	-0.22		0.37	0.29	0.37	0.22	0.23	0.17	0.78	0.16	0.3	0.17
Other Current Liab	0.94	0.92	-0.61	-0.93	0.65	0.92	0.94	0.96	0.94	0.26	0.69	0.94	0.62	0.74	0.2	0.37		0.85	0.98	0.91	0.92	0.84	0.69	0.77	-0.44	0.84
Accounts Payable	0.88	0.83	-0.75	-0.8	0.8	0.84	0.82	0.86	0.87	0.33	0.79	0.95	0.63	0.83	0.26	0.29	0.85		0.84	0.96	0.91	0.77	0.74	0.47	-0.35	0.77
Other Current Assets	0.92	0.91	-0.6	-0.92	0.64	0.9	0.94	0.95	0.92	0.22	0.65	0.93	0.58	0.69	0.15	0.37	0.98	0.84		0.91	0.91	0.85	0.67	0.75	-0.44	0.85
Non Current Assets Total	0.88	0.85	-0.7	-0.84	0.75	0.84	0.91	0.89	0.87	0.29	0.7	0.98	0.56	0.74	0.23	0.22	0.91	0.96	0.91		0.94	0.87	0.62	0.53	-0.5	0.87
Non Currrent Assets Other	0.96	0.95	-0.74	-0.79	0.77	0.95	0.86	0.89	0.95	0.15	0.62	0.98	0.79	0.71	0.08	0.23	0.92	0.91	0.91	0.94		0.72	0.59	0.69	-0.58	0.71
Property Plant And Equipment Net	0.67	0.63	-0.34	-0.82	0.4	0.61	0.94	0.79	0.66	0.41	0.68	0.83	0.19	0.65	0.36	0.17	0.84	0.77	0.85	0.87	0.72		0.54	0.52	-0.36	1.0
Current Deferred Revenue	0.74	0.7	-0.64	-0.8	0.68	0.72	0.58	0.82	0.74	0.23	0.68	0.63	0.44	0.7	0.17	0.78	0.69	0.74	0.67	0.62	0.59	0.54		0.41	0.16	0.54
Short Term Investments	0.73	0.73	-0.18	-0.61	0.2	0.73	0.75	0.68	0.74	0.11	0.47	0.67	0.68	0.55	0.04	0.16	0.77	0.47	0.75	0.53	0.69	0.52	0.41		-0.41	0.51
Common Stock Total Equity	-0.39	-0.44	0.25	0.27	-0.24	-0.41	-0.46	-0.31	-0.38	0.15	0.02	-0.51	-0.4	-0.05	0.16	0.3	-0.44	-0.35	-0.44	-0.5	-0.58	-0.36	0.16	-0.41		-0.35
Property Plant And Equipment Gross	0.66	0.62	-0.33	-0.81	0.4	0.6	0.94	0.79	0.65	0.41	0.68	0.83	0.18	0.65	0.36	0.17	0.84	0.77	0.85	0.87	0.71	1.0	0.54	0.51	-0.35

Click cells to compare fundamentals

Aadi Bioscience Account Relationship Matchups

Aadi Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Total Stockholder Equity	36.5M	(12.4M)	136.4M	158.4M	105.2M	110.5M
Net Debt	(38.4M)	5.8M	(148.4M)	(37.4M)	(55.9M)	(53.1M)
Retained Earnings	(142.2M)	(32.6M)	(142.7M)	(203.2M)	(269.0M)	(255.5M)
Cash	38.5M	4.5M	149.0M	39.0M	62.9M	66.0M
Cash And Short Term Investments	38.5M	4.5M	149.0M	172.6M	108.8M	114.3M
Common Stock Shares Outstanding	2.7M	2.5M	8.9M	22.5M	26.9M	28.3M
Liabilities And Stockholders Equity	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Other Stockholder Equity	179.1M	20.2M	279.1M	361.7M	374.1M	392.8M
Total Current Assets	39.6M	18.7M	151.3M	180.0M	124.6M	130.8M
Total Current Liabilities	3.3M	30.1M	15.3M	18.8M	26.4M	27.7M
Total Liab	3.4M	31.3M	21.5M	25.9M	27.2M	28.6M
Other Current Liab	2.8M	99K	8.7M	14.9M	14.3M	15.0M
Accounts Payable	439.8K	2.4M	6.4M	3.5M	5.9M	6.2M
Other Current Assets	1.0M	81K	2.3M	3.7M	3.8M	4.0M
Non Current Assets Total	366.3K	140K	6.6M	4.2M	7.8M	8.2M
Non Currrent Assets Other	40.0K	(140K)	2.2M	2.1M	1.8M	1.9M
Property Plant And Equipment Net	326.3K	140K	614K	2.0M	6.0M	6.3M
Accumulated Other Comprehensive Income	(335.8K)	(311.1K)	(328.9K)	(115K)	27K	28.4K
Property Plant And Equipment Gross	326.3K	185.6K	614K	2.0M	6.2M	6.6M
Net Tangible Assets	(9.1M)	43.1M	132.6M	158.4M	182.1M	191.2M
Property Plant Equipment	316.0K	121.7K	57K	2.0M	2.3M	2.5M

Currently Active Assets on Macroaxis

DD	Dupont De Nemours
GM	General Motors
BAC	Bank of America
C	Citigroup
V	Visa Class A

When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:

How To Invest In Aadi

Details

Is Aadi Stock a good investment?

Details

What is Aadi Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.

	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Share Portfolio Track or share privately all of your investments from the convenience of any device

Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.55)

Revenue Per Share

0.885

Quarterly Revenue Growth

(0.09)

Return On Assets

(0.33)

Return On Equity

(0.58)

The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aadi Short Term Investments vs Capital Stock Analysis

Short Term Investments vs Capital Stock

Short Term Investments vs Capital Stock Correlation Analysis

Correlation Coefficient

Short Term Investments

Capital Stock

Aadi Bioscience fundamental ratios Correlations

Aadi Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aadi Bioscience fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Aadi Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Short Term Debt	+ 1.0	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Other Current Liab	- 0.93	Retained Earnings
Other Current Assets	- 0.92	Retained Earnings
Total Current Assets	- 0.85	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings